TY - JOUR AU - Tansir, Ghazal AU - Rastogi, Sameer AU - Barwad, Adarsh AU - Dhamija, Ekta PY - 2020 DA - 2020/08/27 TI - Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma JO - Clinical Sarcoma Research SP - 16 VL - 10 IS - 1 AB - Mesenchymal chondrosarcoma is an exceedingly rare malignancy, accounting for around 5% of all patients with chondrosarcoma. It is a translocation-related sarcoma that tends to have both local and distant recurrences. Surgery is the mainstay of treatment in localised cases however treatment of advanced cases remains a challenge. The rarity of the disease precludes dedicated clinical trials and hence guidelines for its management are not well defined. The dearth in literature makes it pertinent that the cases treated with newer therapies must be reported to contribute to existing knowledge. SN - 2045-3329 UR - https://doi.org/10.1186/s13569-020-00138-4 DO - 10.1186/s13569-020-00138-4 ID - Tansir2020 ER -